PyInvesting

Market research

PGZ.F Healius Limited

F EUR Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
179M
P/E ratio
Not available
Analyst target
Not available
Dividend yield
Not available
Beta
0.28

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 4 months ago

Healius Limited is currently in a long term uptrend where the price is trading 18.3% above its 200 day moving average.

From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.6.

Healius Limited's total revenue sank by 0.0% to $473M since the same quarter in the previous year.

Its net income has dropped by 0.0% to $33M since the same quarter in the previous year.

Finally, its free cash flow grew by 149.2% to $126M since the same quarter in the previous year.

Based on the above factors, Healius Limited gets an overall score of 3/5.